Healthy Skepticism Library item: 8807

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Johnson A.
J&J Probes Escalate With New Subpoenas
Wall Street Journal 2007 Mar 13
http://users2.wsj.com/lmda/do/checkLogin?mg=wsj-users2&url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB117371068144034109.html%3Fmod%3DdjemHL

Full text:

Federal prosecutors are stepping up probes into Johnson & Johnson’s marketing of prescription drugs, as three U.S. Attorney’s offices issued subpoenas into how the company supervises subsidiaries selling the medicines.

The subpoenas indicate an escalation of the government’s interest in the way the health-care conglomerate watches over its far-flung and largely independent business units. Drugs in the spotlight include J&J’s best-selling product, antipsychotic Risperdal; Topamax, a treatment for epilepsy and migraines; and Natrecor, for patients suffering from severe heart failure.

Government probes into the marketing of these drugs had been made public previously. The New Brunswick, N.J., health-care giant has …